Proteome Sciences PLC Director/PDMR Shareholding & Total Voting Rights (4191O)
November 04 2016 - 10:52AM
UK Regulatory
TIDMPRM
RNS Number : 4191O
Proteome Sciences PLC
04 November 2016
Proteome Sciences plc
(the "Company")
Director/PDMR Shareholding & Total Voting Rights
Proteome Sciences plc (AIM:PRM) announces that further to the
announcement on 31 October 2016 regarding a placing (the "Placing")
to raise GBP3.3 million, the first tranche of 45,593,346 ( new
ordinary shares of 1 pence each in the capital of the Company
("Ordinary Shares") have today been admitted to trading on AIM
("Admission").
Jeremy Haigh, Chief Executive Officer of the Company, and Roger
McDowell, Non-Executive Director of the Company, both participated
in the Placing. The number of Placing Shares purchased by the
Directors and their beneficial interest in the capital of the
Company is set out below:
No. of new Resultant number Interest in
Ordinary Shares of Ordinary total issued
purchased Shares following share capital
the Placing following the
Placing
---------------- ----------------- ------------------ ---------------
Jeremy Haigh 400,000 400,000 0.15%
---------------- ----------------- ------------------ ---------------
Roger McDowell 2,000,000 2,500,000 0.91%
---------------- ----------------- ------------------ ---------------
Following Admission, the Company's issued share capital is
273,660,078 Ordinary Shares. The above figure of 273,660,078 may be
used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure and Transparency Rules.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities / person closely associated
--- -------------------------------------------------------------------
a) Name Jeremy Haigh
--- ------------------------------- ----------------------------------
2. Reason for the Notification
--- -------------------------------------------------------------------
a) Position/status Chief Executive Officer
--- ------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
--- ------------------------------- ----------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------
a) Name Proteome Sciences plc
--- ------------------------------- ----------------------------------
b) LEI n/a
--- ------------------------------- ----------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------------
a) Description of Ordinary Shares of 1p each
the Financial
instrument, type
of instrument
---
Identification GB0003104196
code
--- ------------------------------- ----------------------------------
b) Nature of the Subscription to purchase Ordinary
transaction Shares
--- ------------------------------- ----------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
5p 400,000
--------- ----------
--- ------------------------------- ----------------------------------
d) Aggregated information:
* Aggregated volume 400,000 Ordinary Shares of
1 pence each purchased at
5 pence per Ordinary Share
* Price
--- ------------------------------- ----------------------------------
e) Date of the transaction 4 November 2016
--- ------------------------------- ----------------------------------
f) Place of the London Stock Exchange, AIM
transaction Market (XLON)
--- ------------------------------- ----------------------------------
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities / person closely associated
--- -----------------------------------------------------------------
a) Name Roger McDowell
--- ------------------------------- --------------------------------
2. Reason for the Notification
--- -----------------------------------------------------------------
a) Position/status Non-Executive Director
--- ------------------------------- --------------------------------
b) Initial notification/Amendment Initial notification
--- ------------------------------- --------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------------
a) Name Proteome Sciences plc
--- ------------------------------- --------------------------------
b) LEI n/a
--- ------------------------------- --------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------------
a) Description of Ordinary Shares of 1p each
the Financial
instrument, type
of instrument
---
Identification GB0003104196
code
--- ------------------------------- --------------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
--- ------------------------------- --------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
5p 2,000,000
--------- ----------
--- ------------------------------- --------------------------------
d) Aggregated information:
* Aggregated volume 2,000,000 Ordinary Shares
of 1 pence each purchased
at 5 pence per Ordinary Share
* Price
--- ------------------------------- --------------------------------
e) Date of the transaction 4 November 2016
--- ------------------------------- --------------------------------
f) Place of the London Stock Exchange, AIM
transaction Market (XLON)
--- ------------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEZLFBQFFZFBK
(END) Dow Jones Newswires
November 04, 2016 11:52 ET (15:52 GMT)